B
JAZZ icon

BancorpSouth’s Jazz Pharmaceuticals JAZZ Stock Holding History

BancorpSouth’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$479K Buy
3,273
+103
+3% +$15.6K 0.05% 140
2017
Q2 		$493K Buy
3,170
+321
+11% +$49.1K 0.05% 126
2017
Q1 		$413K Buy
2,849
+734
+35% +$95.6K 0.04% 138
2016
Q4 		$231K Buy
+2,115
New +$236K 0.03% 193

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BancorpSouth's JAZZ Position: Q3 2017 in Review

BancorpSouth increased its Jazz Pharmaceuticals (JAZZ) stake by 3.2% in Q3 2017, buying an estimated $15.6K and bringing the position to 3,273 shares worth $479K. The position accounts for 0.05% of the portfolio, ranked #140.

BancorpSouth first reported a position in JAZZ in Q4 2016 and has held it in 4 quarters since. The position peaked at $493K in Q2 2017. 303 funds tracked by Wall St. Rank hold JAZZ as of Q3 2017.

  • BancorpSouth held 3,273 shares of Jazz Pharmaceuticals worth $479K as of Q3 2017.
  • BancorpSouth bought 103 Jazz Pharmaceuticals shares in Q3 2017, an estimated $15.6K.
  • Jazz Pharmaceuticals made up 0.05% of BancorpSouth's portfolio in Q3 2017, its #140 holding.
  • BancorpSouth first reported a position in Jazz Pharmaceuticals in Q4 2016 and has held it in 4 quarters since.
  • BancorpSouth's Jazz Pharmaceuticals position peaked at $493K in Q2 2017.
  • 303 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2017.

Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.